Advances in Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation for the Neonate and Infant

World Journal for Pediatric and Congenital Heart Surgery

Volumn 1, Issue 2, 2010, Pages 217-225

  Jonas, Richard A ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

cardiopulmonary bypass; congenital heart disease; congenital heart surgery; extracorporeal membrane oxygenation

Indexed keywords

EID: 84990359351     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135110372638     Document Type: Article

References (28)

1. Aoki M, Nomura F, Stromski ME, et al. Effects of pH on brain energetics after hypothermic circulatory arrest. Ann Thorac Surg. 1993; 55: 1093–2103.
2. Jonas RA. Optimal pH strategy for cardiopulmonary bypass in neonates, infants and children. Perfusion. 1998; 13: 277–287.
3. Jonas RA, Bellinger DC, Rappaport LA, et al. Relation of pH strategy and developmental outcome after hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 1993; 106: 362–368.
4. Duebener L, Hagino I, Sakamoto T, et al. Effects of pH management during deep hypothermic bypass on cerebral microcirculation: alpha stat vs pH stat. Circulation. 2002; 106: I103–I108.
5. Hiramatsu T, Miura T, Forbess JM, et al. PH strategy and cerebral energetics before and after circulatory arrest. J Thorac Cardiovasc Surg. 1995; 109: 948–958.
6. Bellinger DC, Wypij D, du Plessis AJ, et al. Developmental and neurologic effects of alpha stat versus pH stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 2001; 121: 374–383.
7. du Plessis AJ Jonas RA Wypij D, et al. Perioperative effects of alpha stat versus ph stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 1997; 114: 991–1001.
8. Jonas RA. Cardiac surgery and neurological injury in children. Heart Lung Circ. 2000; 9: 16–22.
9. Shin’oka T Shum-Tim D Jonas RA Lidov HGW Laussen PC Miura T du Plessis A. Higher hematocrit improves cerebral outcome after deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg 1996; 112: 1610–1621.
10. Shin’oka T Shum-Tim D Laussen PC Zinkovsky SM Lidov HGW du Plessis A Jonas RA. Effects of oncotic pressure and hematocrit on outcome after hypothermic circulatory arrest. Ann Thorac Surg 1998; 65: 155–164.
11. Sakamoto T, Zurakowski D, Duebener LF, et al. Combination of alpha stat strategy and hemodilution exacerbates neurologic injury in a survival piglet model with deep hypothermic circulation arrest. Ann Thorac Surg. 2002; 73: 180–190.
12. Duebener LF, Sakamoto T, Hatsuoka S, Stamm C, Zurakowski D, Vollmar B, Menger MD, Schafers HJ Jonas RA. Effects of hematocrit on cerebral microcirculation and tissue oxygenation during deep hypothermic bypass. Circulation 2001; 104 (Supplement I) I260–I264.
13. Jonas RA, Wypij D, Roth SJ, et al. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg. 2003; 126: 1765–1774.
14. Chan T, Thiagarajan RR, Frank D Bratton SL. Survival after extracorporeal cardiopulmonary resuscitation in infants and children with heart disease. J Thorac Cardiovasc Surg. 2008; 136: 984.
15. Lequier L, Joffe AR, Robertson CMT, et al. Western Canadian Complex Pediatric Therapies Program Follow-Up Group. Two-year survival, mental, and motor outcomes after cardiac extracorporeal life support at less than 5 years of age. J Thorac Cardiovasc Surg. 2008; 136: 976–983.
16. Murkin JM, Arango M. Near-infrared spectroscopy as an index of brain and tissue oxygenation. Br J Anaesth. 2009; 103: i3–i13.
17. Nollert G, Shin’oka T Jonas RA. Near-infrared spectrophotometry of the brain in cardiovascular surgery. Thorac Cardiovasc Surg. 1998; 46: 167–175.
18. Sakamoto T, Hatsuoka S, Stock UA, et al. Prediction of safe duration of hypothermic circulatory arrest by near-infrared spectroscopy. J Thorac Cardiovasc Surg. 2001; 122: 339–350.
19. Sakamoto T, Zurakowski D, Duebener LF, et al. Combination of alpha-stat strategy and hemodilution exacerbates neurologic injury in a survival piglet model with deep hypothermic circulatory arrest. Ann Thorac Surg. 2002; 73: 180–189.
20. Hagino I, Anttila V, Zurakowski D, Duebener LF, Lidov HG Jonas RA. Tissue oxygenation index is a useful monitor of histologic and neurologic outcome after cardiopulmonary bypass in piglets. J Thorac Cardiovasc Surg. 2005; 130: 384–392.
21. Anttila V, Hagino I, Zurakowski D, et al. Specific bypass conditions determine safe minimum flow rate. Ann Thorac Surg. 2005; 80: 1460–1467.
22. Mangano DT, Tudor IC, Dietzel C. Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006; 354: 353–365.
23. Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2004; 128: 442–448.
24. Aoki M, Jonas RA, Nomura F, et al. Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg. 1994; 58: 146–153.
25. Nicole O. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med. 2001; 7: 59–64.
26. Iwata Y, Nicole O, Okamura T, Zurakowski D Jonas RA. Aprotinin confers neuroprotection by reducing excitotoxic cell death. J Thorac Cardiovasc Surg. 2008; 135: 573–578.
27. Ishibashi N, Iwata Y, Zurakowski D, Lidov HG Jonas RA. Aprotinin protects the cerebral microcirculation during cardiopulmonary bypass. Perfusion. 2009; 24: 99–105.
28. Iwata Y, Okamura T, Ishibashi N, Zurakowski D, Lidov HG Jonas RA. Optimal dose of aprotinin for neuroprotection and renal function in a piglet survival model. J Thorac Cardiovasc Surg. 2009; 137: 1521–1529.